Kumar, Sujeet, et al. “A Real World Analysis of Safety and Efficacy of Nilotinib When Used As First Line and Beyond: Retrospective Single Centre Study Representing Largest Cohort of Indian Patients Treated With Nilotinib”. Asian Pacific Journal of Cancer Biology, vol. 9, no. 2, May 2024, pp. 137-4, doi:10.31557/apjcb.2024.9.2.137-147.